logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

The genetic aspects of endothelial dysfunction in patients with type 2 diabetes mellitus

[Internal diseases]
Irina Khripun; Sergey Vorobyev; Maksim Morgunov; Igor Belousov; Elizaveta Dzantieva; Zalina Gusova; Halid Ibishov; Michail Kogan;

The severity of cardiovascular complications of diabetes mellitus (DM) is subject to numerous factors, including genetic. The aim of the study was to evaluate the effect of s.582+353_379del polymorphism in the endothelial nitric oxide synthase (eNOS3) gene on endothelial function in men with type 2 DM. We examined 144 men with type 2 DM aged 40-65 years. Patients were divided into two groups according to the presence or absence of s.582+353_379del polymorphism in the eNOS3 gene. In patients with the presence of deletion in the 27 pair of nucleotides in intron 4 of the eNOS gene decreased concentrations of nitric oxide, as well as a significant reduction of eNOS3 activity were detected along with the increase of endothelin, VCAM-1, ICAM-1 and E-selectin concentrations which indicates the endothelial dysfunction development. In patients with type 2 DM with s.582+353_379del polymorphism of eNOS3 gene the diameter of the brachial artery during vasodilation was decreased and the severity of endothelium-dependent vasodilation of blood vessels was reduced, which is the clinical manifestation of endothelial dysfunction potentially dangerous in terms of the vascular complications of DM progression.

Download

References:
1. Dedov I. I., Chestakova M. V. Saharniy diabet i arterial’naya gipertenzia. Мoscow: МIА; 2006. 346 p.
2. Kasatkina S. G., Kasatkin S. N. Fundamentalnye issledovaniya. – Fundamental researches. 2011;7:248-252.
3. Rukovodstvo po kardiologii v chetireh tomah. Tom 2: Metodi diagnostiki serdechnososudistih zabolevaniy / pod red. E. I. Chazova. Мoscow:«Praktica»; 2014. 776 р.
4. Capellini V. K., Celotto A. C., Baldo C. F., Olivon V. C., Viaro F., Rodrigues A. J., Evora P. R. Curr. Vasc. Pharmacol. 2010;8(4):526-544.
5. Förstermann U., Sessa W. C. Eur. Heart J. 2012;33(7):829-837.
6. Howangyin K. Y., Silvestre J. S. Arterioscler Thromb. Vasc. Biol. 2014;34(6):1126-1135.
7. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=163729
8. Kampoli A. M., Tousoulis D., Tentolouris C., Stefanadis C. Curr. Vasc. Pharmacol. 2012;10(1):61-76.
9. Lei J., Vodovotz Y., Tzeng E., Billiar T. R. Nitric Oxide. 2013;35:175-185.
10. Sverdlov A. L., Ngo D. T., Chan W. P., Chirkov Y. Y., Horowitz J. D. J. Am. Heart Assoc. 2014;3(4).
11. Tousoulis D., Kampoli A. M., Stefanadis C. Curr. Vasc. Pharmacol. 2012;10(1):19-32.
12. Tousoulis D., Kampoli A. M., Tentolouris C., Papageorgiou N., Stefanadis C. Curr. Vasc. Pharmacol. 2012;10(1):4-18.

Keywords: endothelial dysfunction, diabetes mellitus, endothelium-dependent vasodilation, markers of endothelial dysfunction, s.582+353_379del polymorphism in eNOS3 gene


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy